Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Long-Term Deferred Tax: 2023-2024

Historic Long-Term Deferred Tax for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $1.5 million.

  • Zhengye Biotechnology Holding's Long-Term Deferred Tax was N/A to $2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.3 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2024, which is 10.67% down from last year.
  • Per Zhengye Biotechnology Holding's latest filing, its Long-Term Deferred Tax stood at $1.5 million for FY2024, which was down 10.67% from $1.7 million recorded in FY2023.
  • Zhengye Biotechnology Holding's 5-year Long-Term Deferred Tax high stood at $1.7 million for FY2023, and its period low was $1.5 million during FY2024.
  • In the last 2 years, Zhengye Biotechnology Holding's Long-Term Deferred Tax had a median value of $1.6 million in 2023 and averaged $1.6 million.
  • Data for Zhengye Biotechnology Holding's Long-Term Deferred Tax shows a maximum YoY decreased of 10.67% (in 2024) over the last 5 years.
  • Zhengye Biotechnology Holding's Long-Term Deferred Tax (Yearly) stood at $1.7 million in 2023, then fell by 10.67% to $1.5 million in 2024.